This year's program extends beyond high-content imaging to explore biomolecular imaging & informatics more broadly construed.

The agenda will consider the following:

  • Spatial omics
  • Advanced microscopy platforms
  • Artificial intelligence / machine learning applications
  • High-content, image-based assays
  • 3D, co-culture, organ-on-a-chip imaging

The first day of the conference, Sunday, September 18, will be Education Day, with parallel tracks exploring best practices and unmet needs in biomolecular imaging & informatics. The annual Colloquium will be held that afternoon. Monday and Tuesday will be devoted to keynotes, formal sessions, poster viewings, and exhibiting. The conference will conclude with the Award Ceremony and the SBI2 Annual General Meeting.

The conference will again feature a poster competition and the annual President's Innovation Award. The President's Innovation Award recognizes an early-career researcher who has innovated meaningfully in biomolecular imaging and informatics and who is likely to become a leader in the field.

Updates to the program will be posted as they become available, so please check back!

Register Now

Keynote Speakers

Garry P. Nolan, PhD
Professor, Pathology
Baxter Laboratory, Stanford University

Chris Gibson, PhD
CEO and Co-founder
Recursion Pharmaceuticals

Formal sessions

Monday, September 19, 2022
Session I: Integration of Spatial Image-Omics With Data Analysis Tools
Chairs: Don Apanovitch (Ferring Pharma), Sizun Jiang (Beth Israel Deaconess Medical Center)

Session II: Enhancing Translatability With Imaging: 3D models, Co-culture, and Organ-on-a-Chip
Chairs: Jason Ekert (GSK), Scott Cribbes (PerkinElmer)

Tuesday, September 20, 2022
Session III: Advances in High-Content Imaging: Next Generation Phenotypic Screening Assays

Chairs: Erin Edwards (GSK), David Shum (Institut Pasteur Korea), Steve Walker (Abbvie)

Session IV: Artificial Intelligence / Machine Learning in Biomolecular Imaging: Successes and Challenges
Chairs: Greg Way (University of Colorado), Heba Sailem (University of Oxford)